Xu CX - Search Results

1

KRAS^Q61H Preferentially Signals through MAPK in a RAF Dimer-Dependent Manner in Non-Small Cell Lung Cancer.

Zhou ZW, Ambrogio C, Bera AK, Li Q, Li XX, Li L, Son J, Gondi S, Li J, Campbell E, Jin H, Okoro JJ, Xu CX, Janne PA, Westover KD. Zhou ZW, et al. Among authors: xu cx. Cancer Res. 2020 Sep 1;80(17):3719-3731. doi: 10.1158/0008-5472.CAN-20-0448. Epub 2020 Jun 30. Cancer Res. 2020. PMID: 32605999 Free article.

2

Apoptosis and apoptosis-based therapy in lung cancer.

Xu CX, Jin H, Cho MH. Xu CX, et al. Anticancer Agents Med Chem. 2009 Nov;9(9):952-7. doi: 10.2174/187152009789377682. Anticancer Agents Med Chem. 2009. PMID: 19663788 Review.

3

Low dietary inorganic phosphate stimulates lung tumorigenesis through altering protein translation and cell cycle in K-ras(LA1) mice.

Xu CX, Jin H, Lim HT, Ha YC, Chae CH, An GH, Lee KH, Cho MH. Xu CX, et al. Nutr Cancer. 2010;62(4):525-32. doi: 10.1080/01635580903532432. Nutr Cancer. 2010. PMID: 20432174

4

Roles of protein kinase B/Akt in lung cancer.

Xu CX, Jin H, Shin JY, Kim JE, Cho MH. Xu CX, et al. Front Biosci (Elite Ed). 2010 Jun 1;2(4):1472-84. doi: 10.2741/e206. Front Biosci (Elite Ed). 2010. PMID: 20515818 Free article. Review.

5

Decreased expression of miR216a contributes to non-small-cell lung cancer progression.

Wang RT, Xu M, Xu CX, Song ZG, Jin H. Wang RT, et al. Among authors: xu m, xu cx. Clin Cancer Res. 2014 Sep 1;20(17):4705-16. doi: 10.1158/1078-0432.CCR-14-0517. Epub 2014 Jun 23. Clin Cancer Res. 2014. PMID: 24958806

6

miR-382 inhibits tumor growth and enhance chemosensitivity in osteosarcoma.

Xu M, Jin H, Xu CX, Sun B, Mao Z, Bi WZ, Wang Y. Xu M, et al. Among authors: xu cx. Oncotarget. 2014 Oct 15;5(19):9472-83. doi: 10.18632/oncotarget.2418. Oncotarget. 2014. PMID: 25344865 Free PMC article.

7

A high risk of osteosarcoma in individuals who are homozygous for the p.D104N in endostatin.

Bi WZ, Li DW, Luo S, Song ZG, Wang Y, Jin H, Wang Y, Li Q, Li MX, Wang D, Sun B, Xu M, Xu CX. Bi WZ, et al. Among authors: xu m, xu cx. Sci Rep. 2015 Nov 6;5:16392. doi: 10.1038/srep16392. Sci Rep. 2015. PMID: 26542764 Free PMC article.

8

IKBKE Is a Substrate of EGFR and a Therapeutic Target in Non-Small Cell Lung Cancer with Activating Mutations of EGFR.

Challa S, Guo JP, Ding X, Xu CX, Li Y, Kim D, Smith MA, Cress DW, Coppola D, Haura EB, Cheng JQ. Challa S, et al. Among authors: xu cx. Cancer Res. 2016 Aug 1;76(15):4418-29. doi: 10.1158/0008-5472.CAN-16-0069. Epub 2016 Jun 10. Cancer Res. 2016. PMID: 27287717 Free PMC article.

9

miR-424 acts as a tumor radiosensitizer by targeting aprataxin in cervical cancer.

Wang X, Li Q, Jin H, Zou H, Xia W, Dai N, Dai XY, Wang D, Xu CX, Qing Y. Wang X, et al. Among authors: xu cx. Oncotarget. 2016 Nov 22;7(47):77508-77515. doi: 10.18632/oncotarget.12716. Oncotarget. 2016. PMID: 27769049 Free PMC article.

10

miR-491 Inhibits Osteosarcoma Lung Metastasis and Chemoresistance by Targeting αB-crystallin.

Wang SN, Luo S, Liu C, Piao Z, Gou W, Wang Y, Guan W, Li Q, Zou H, Yang ZZ, Wang D, Wang Y, Xu M, Jin H, Xu CX. Wang SN, et al. Among authors: xu m, xu cx. Mol Ther. 2017 Sep 6;25(9):2140-2149. doi: 10.1016/j.ymthe.2017.05.018. Epub 2017 Jun 23. Mol Ther. 2017. PMID: 28648665 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

357 results

Search Page

Filters